HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Abstract
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.
AuthorsP R Lyons, P K Newman, M Saunders
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 51 Issue 2 Pg. 285-7 (Feb 1988) ISSN: 0022-3050 [Print] England
PMID3346696 (Publication Type: Journal Article)
Chemical References
  • Prednisolone
  • Methylprednisolone
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Dose-Response Relationship, Drug
  • Humans
  • Infusions, Intravenous
  • Methylprednisolone (administration & dosage, adverse effects)
  • Middle Aged
  • Multiple Sclerosis (drug therapy)
  • Prednisolone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: